Moving the needle on vaccine preventable diseases.
MMGH uses a unique combination of rigorous academic research, tailor-made teams, specialist knowledge, industry-specific experience, state-of-the-art tools and independent thinking, to provide trusted advice and implementable solutions for programmes and products related to Vaccine Preventable Diseases, and Neglected Tropical Diseases, within the public health sphere.
Filters
Focus Areas
Vaccine Preventable Diseases
Image Credit: MMGH/Carsten Mantel
2022 — Ongoing
COVID-19 vaccine post-introduction evaluations (cPIEs) in low- and middle-income countries...
MMGH is supporting the Task Force for Global Health, US CDC and WHO in conducting cPIEs in 8 countries. This includes the development of generic training materials for the online…
Client
Task Force for Global Health
Task Force for Global Health
2022 — Ongoing
Supporting the creation of a learning and performance management vision...
In partnership with Jhpiego, MMGH is supporting Gavi, the Vaccine Alliance to establish a set of global quality standards and requirements for the learning and performance management (LPM) approaches and…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
2021 — Ongoing
Papua New Guinea Measles & Rubella campaign...
MMGH is supporting Papua New Guinea in applying for Gavi funds needed to plan and implement a Measles & Rubella (MR) follow-up campaign. The campaign will also include a routine…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
2021 — Ongoing
Piloting approaches for the national cholera plan and GTFCC execution...
In partnership with Global Health Visions, providing support to the Global Task Force on Cholera Control (GTFCC) and the Country Support Platform to develop an approved methodology to support the…
Client
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
2021 — 2022
Assessment of the Factors Enabling the Rapid Development and Authorisation...
MMGH conducted an assessment on behalf of the Wellcome Trust to understand the impact of different factors which enabled the rapid clinical development and regulatory authorisation for COVID-19 vaccines. The…
Client
Wellcome Trust
Wellcome Trust
Image Credit: Vaxxas
2021 — Ongoing
Definition and market sizing of the use cases for micro-array...
MMGH is supporting the Vaccine Innovation Prioritisation Strategy on defining potential use cases for Typhoid Conjugate Vaccine microarray patches (TCV-MAPs) this work will include a demand forecast of the potential…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
2021 — Ongoing
MR-MAPs initial Full Vaccine Value Assessment...
In partnership with the London School of Hygiene and Tropical Medicine and Global Health Visions, support the development of an initial Full Vaccine Value Assessment of Measles-Rubella micro-array patches (MR-MAPs),…
Client
UNICEF
UNICEF
2021 — Ongoing
Support to GTFCC to develop training materials related to the...
MMGH is supporting the GTFCC and its partners in developing the training materials for a 5-day training session. The training targets country stakeholders that are engaged in the preparation, implementation,…
Client
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC)
2021 — Ongoing
Evaluating WHO’s role in supporting early COVID-19 sero-epidemiologic studies: the...
MMGH is evaluating WHO Health Emergency Program’s role in supporting countries to conduct COVID-19 sero-epidemiologic investigations, the "Unity initiative". This initiative developed scientifically vetted and standardised protocols to facilitate the…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Marco Verch
2021 — Ongoing
Evaluation of the European Vaccine Action Plan 2015-2020...
MMGH is supporting the WHO Regional Office for Europe (EURO) in performing the review of the European Vaccine Action Plan (EVAP) 2015-2020. MMGH is collating and analysing available information to…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2021 — 2021
Seasonal influenza vaccine value proposition: Definition of use cases and...
As part of the global effort to conduct a full-value of seasonal influenza vaccine assessment, MMGH supported WHO to conduct a scoping assessment and literature review of past, ongoing and…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: CDC
2021 — 2021
Mid-term review of the Coalition for Epidemic Preparedness Innovation...
MMGH supported the Coalition for Epidemic Preparedness Innovation (CEPI) in conducting a Mid-Term Review (MTR) of their operations since inception (2017) to 2020. The project approach consisted of a document…
Client
CEPI
CEPI
Related Publication(s)
CEPI mid-term review and COVID-19 response review: combined report
CEPI mid-term review and COVID-19 response review: combined report
2021 — Ongoing
Support to WHO SAGE Secretariat...
MMGH is supporting the SAGE secretariat with summarizing SAGE deliberations and with drafting and finalizing the report of the regular SAGE meeting in October 2021.
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2021 — Ongoing
Rapid Vaccine Manufacturing Diagnostic Study...
MMGH is assisting the Inter-American Development Bank to prepare a rapid vaccine supply diagnostic study in support of work aimed at generating capacities in the countries that integrate PROSUR to…
Client
Inter American Deelopment Bank
Inter American Deelopment Bank
2021 — 2021
Regional manufacturing of COVID-19 vaccines...
MMGH is assisting the Asian Development Bank's Interdepartmental Vaccine Manufacturing Task Force to assess demand for COVID-19 vaccines and vaccine manufacturing capacity in developing countries in Asia and Pacific.
Client
Asian Development Bank
Asian Development Bank
2021 — Ongoing
Seasonal influenza vaccine value proposition: Development of a generic use...
MMGH is supporting the US CDC and WHO to validate preliminary use cases and country archetypes previously developed for seasonal influenza vaccines. MMGH is conducting staekholder surveys, interviews and workshops…
Client
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC)
2021 — Ongoing
Strengthen Philippines Vaccine Manufacturing...
In collaboration with a team of experts, MMGH is assisting The Asian Development Bank (ADB) to support the Department of Health and the Research Institute for Tropical Medicine (RITM) from…
Client
Asian Development Bank
Asian Development Bank
Image Credit: United Nations
2020 — 2021
COVID-19 Support to Coalition for Epidemic Preparedness Innovation (CEPI)...
MMGH supported the Coalition for Epidemic Preparedness Innovation (CEPI) in conducting a review of its response to the SARS-CoV-2 pandemic in the first nine months of 2020. The project approach…
Client
CEPI
CEPI
Related Publication(s)
CEPI mid-term review and COVID-19 response review: combined report
CEPI mid-term review and COVID-19 response review: combined report
2020 — 2022
COVID-19 Support to World Health Organisation...
MMGH is supporting the Country Readiness and Delivery (CRD) workstream of the COVAX Facility, under the vaccines pillar of the ACT Accelerator, through technical support to the WHO & UNICEF…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Jake Nebov
2020 — 2021
COVID-19 Supply Chain System Assessment...
MMGH supported The Yellow House consulting agency in performing an outside-in assessment of the United Nations’ COVID-19 Supply Chain System setup, performance, and activities to date. Leveraging the output of…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2020 — 2021
Evaluation of linking supplementary immunisation activities and routine immunisation in...
MMGH assisted the WHO Country Office and Ministry of Health (MoH) Nepal in the evaluation of a new initiative linking supplementary immunisation activities (SIAs), against measles and rubella, with intensified…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2020 — Ongoing
Development of European Region Immunisation Agenda 2030...
MMGH is supporting the WHO European Regional Office (EURO) in developing the Regional Immunisation Agenda for the period 2021-2030 in alignment with the Global Immunisation Agenda 2030 (IA2030).
Client
World Health Organization (WHO)
World Health Organization (WHO)
Image Credit: MMGH/Carsten Mantel
2020 — Ongoing
Evaluating the impact of electronic Logistic Management Information Systems (eLMIS)...
MMGH, in partnership with Bocconi University, is conducting an evaluation of electronic Logistic Management Information Systems (eLMIS) and electronic Immunisation Registries (EIR) in low- and middle-income countries. Funded by the…
Client
Bill and Melinda Gates Foundation, World Health Organisation (WHO), Gavi, The Vaccine Alliance
Bill and Melinda Gates Foundation, World Health Organisation (WHO), Gavi, The Vaccine Alliance
Image Credit: Swarnavo Chakrabarti
2020 — 2020
Definition of barriers and drivers of an effective vaccine development...
MMGH supported the Wellcome Trust in mapping and sizing the factors influencing vaccine developers’ decisions in progressing along the development pathway: from transition into Phase II clinical trials to early…
Client
Wellcome Trust
Wellcome Trust
Related Publication(s)
Understanding the vaccine ecosystem: structure and challenges
Understanding the vaccine ecosystem: structure and challenges
Image Credit: Gavi, the Vaccine Alliance
2020 — 2021
COVID-19 Support to Gavi, the Vaccine Alliance...
MMGH supported Gavi, the Vaccine Alliance by documenting and synthesizing its key decisions related to the COVAX Facility and COVAX Advance Market Commitment (AMC). Activities include a desk review, key…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
Image Credit: Akiko Harayama
2020 — Ongoing
Definition of prioritised research agenda to support the implementation of...
In collaboration with the Global Task Force on Cholera Control (GTFCC), MMGH developed a Research Agenda aligned to the Roadmap. The Research Agenda serves as a guide for the allocation…
Client
Wellcome Trust
Wellcome Trust
Image Credit: Helena Spongenberg
2020 — Ongoing
Development of the European Immunisation Agenda 2030 (EIA2030) Operational Framework...
MMGH is supporting the WHO European Regional Office (EURO) in developing its operational framework for its European Immunisation Strategy 2030 (EIA2030 Strategy). The operational framework will focus on how the…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: CDC
2019 — 2019
Leishmaniasis vaccine product development plan...
MMGH created a product development plan to guide the University of York in the further development of a candidate leishmaniasis vaccine. The plan incorporates the definition of a target product…
Client
University of York
University of York
Image Credit: CDC
2019 — 2019
Identification of alternative strategies for the Meningitis International Coordinating Group...
MMGH supported the International Coordinating Group (ICG) for meningitis to improve access to vaccines for the international stockpile. The project sought to understand the reasons for supply constraints of vaccine…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2019 — Ongoing
Advocacy for the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) project...
MMGH is part of the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) consortium, made up of 12 partners from eight different countries including three disease-endemic countries. The initiative advances the development…
Client
EU Commission
EU Commission
2019 — Ongoing
Definition and market sizing of the use cases for micro-array...
MMGH supports the WHO's Vaccine Product & Delivery Research department in defining and sizing (including a demand forecast) the use cases for a Measles Rubella vaccine micro-array patch (MAP). The…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: CDC
2019 — 2020
Demand forecast and financial sustainability analysis for a group B...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in developing a variety of forecast scenarios for the demand of a group B streptococcal (GBS) vaccine administered through maternal immunisation.…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2019 — 2020
Operationalisation of group B streptococcal maternal vaccination...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in preparing a report on the considerations for operationalising group B streptococcal (GBS) maternal vaccination as part of a Public Health…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Mika Baumeister
2019 — 2020
Development of European Region Immunisation Agenda 2030...
MMGH supported the Bill & Melinda Gates Foundation in assessing the public health and financial viability of a macrofilaricide drug to accelerate the elimination of onchocerciasis. MMGH coordinated the definition…
Client
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
2019 — 2019
Implementing the Ending Cholera: A Global Roadmap to 2030 Strategy...
MMGH assisted the Global Task Force on Cholera Control (GTFCC), on a Bill & Melinda Gates Foundation grant, in establishing an Oral Cholera Vaccine (OCV) demand forecast platform, a programme…
Client
Global Task Force on Cholera Control
Global Task Force on Cholera Control
2019 — 2019
Evaluation of the INCLEN Childhood Pneumonia Program in India...
MMGH supported an external evaluation of a project funded by the Bill & Melinda Gates Foundation and coordinated by INCLEN Trust International in an effort to control childhood pneumonia. The…
Client
The INCLEN Trust International
The INCLEN Trust International
2019 — 2019
Improving access to affordable vaccine supply in Member States of...
MMGH supported the Vaccine-Preventable Diseases and Immunisation Unit of WHO Europe in operationalising the South-Eastern Europe Health Network (SEEHN) vision and principles which focus on securing access to sufficient and…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2019 — 2019
Application for Gavi support for human papillomavirus vaccine introduction in...
MMGH assisted the National Immunisation Program (NIP), Ministry of Health Cambodia, and the WHO Country Office in Phnom Penh with the Gavi application process for the introduction of the human…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Stefano Malvolti
2019 — 2019
Evaluation of WHO’s Strategic Advisory Group of Experts on Immunisation...
MMGH supported the WHO Department of Immunisation, Vaccines and Biologicals (IVB) and the Expert Advisory Group on SAGE Evaluation (EAGSE) in assessing the relevance, effectiveness and quality of SAGE's processes…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2019 — 2019
Evaluation of the Global Vaccine Action Plan 2011-2020...
MMGH supported the WHO Department of Immunisation, Vaccines and Biologicals (IVB) in the evaluation of strengths and weaknesses of the current Global Vaccine Action Plan (GVAP), its monitoring and evaluation…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Related Publication(s)
Global Vaccine Action Plan 2011-2020 – Review and Lessons Learned: Strategic Advisory Group of Experts on Immunisation, Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives, Global Vaccine Action Plan Lessons Learned III: Monitoring and evaluation/accountability framework, The global vaccine action plan monitoring and evaluation/ accountability framework: Perspective
Global Vaccine Action Plan 2011-2020 – Review and Lessons Learned: Strategic Advisory Group of Experts on Immunisation, Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives, Global Vaccine Action Plan Lessons Learned III: Monitoring and evaluation/accountability framework, The global vaccine action plan monitoring and evaluation/ accountability framework: Perspective
Image Credit: MMGH/Thomas Cherian
2019 — 2019
Evaluations in tier 2 surveillance sites for the National Surveillance...
MMGH conducted an independent external evaluation of the tier 2 sites of the National Surveillance System for Enteric Fever in India (NSSEFI). These sites are secondary level hospitals, conducting surveillance…
Client
Christian Medical College
Christian Medical College
Image Credit: Yasmina Guerda
2019 — 2019
Guidance to support countries introducing health worker influenza vaccination...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in reviewing the scientific evidence on health worker (HW) influenza vaccination, collating currently available immunisation strategies, and synthesising a practical introduction…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Unicef
2019 — 2020
Measles and Rubella Strategic Framework 2021-2030...
MMGH supported the Measles & Rubella Initiative (M&RI) in the definition of the post-2020 global strategic framework in alignment with the Immunisation Agenda 2030 (IA2030). After performing a situational analysis…
Client
Measles and Rubella Initiative
Measles and Rubella Initiative
2019 — 2019
Redesign of the Eliminate Yellow Fever programme governance and work...
MMGH supported the Eliminate Yellow Fever (EYE) Secretariat at WHO in streamlining programme governance and defining the general lines of action to serve as the foundation of a three-year multi-agency…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2019 — 2019
Human Papillomavirus (HPV) affordability analysis...
MMGH supported the WHO Department of Immunisation and Biologicals (IVB) in defining a logical framework to assess the barriers to access human papillomavirus (HPV) vaccine in middle-income countries, with a…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018
Development of a comprehensive Multi-Year Plan in Lao PDR...
MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in the review of the National Immunisation Program (NIP) and the establishment and update of a…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: IOC/Fiocruz/Gutemberg Brito
2018 — 2018
Development of the business case for a Schistosomiasis vaccine...
MMGH supported the Bill & Melinda Gates Foundation in assessing the public health and financial viability of a vaccine against Schistosomiasis. MMGH coordinated a group of experts in developing vaccine…
Client
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
2018 — 2018
Preparation for the Cholera Roadmap implementation...
MMGH assisted the Global Task Force on Cholera Control (GTFCC), supported by a Bill & Melinda Gates Foundation grant, in establishing an oral cholera vaccine (OCV) demand forecast platform, a…
Client
Global Task Force on Cholera Control
Global Task Force on Cholera Control
2018 — 2018
Gap analysis of existing information on acceptability and access to...
MMGH supported the Barcelona Institute for Global Health (ISGlobal) and PATH in conducting a gap analysis of existing evidence and information on the acceptability and access to maternal immunisation. This…
Client
ISGlobal
ISGlobal
2018 — 2018
Mid-Term evaluation of the European Vaccine Action Plan...
MMGH supported the WHO Regional Office for Europe (EURO) in performing the mid-term review of the European Vaccine Action Plan (EVAP) 2015-2020. MMGH collated and analysed available information to measure…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018
Evaluation of the enteric fever surveillance pilot programme in Ghana...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in assessing the feasibility and reliability of integrating surveillance of enteric fever (EF) and invasive non-typhoidal salmonellosis (iNTS) in the WHO-coordinated…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Lorenzo Pezzoli
2018 — 2018
Development of the Oral Cholera Vaccine preferred product characteristics...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in updating the Preferred Product Characteristics for the Oral Cholera Vaccine. MMGH facilitated the expert meeting and coordinated the drafting of…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Stefano Malvolti
2018 — 2018
Definition of a capacity building plan for Gavi’s Country Programmes...
MMGH supported the Country Programmes department of the Gavi Secretariat in defining its competency model and related training programmes. Partnering with Gavi’s Human Resource and Knowledge Management department and conducting…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
Image Credit: MMGH/Thomas Cherian
2018 — 2018
Definition of a support framework for the establishment of Programme...
MMGH assisted the Gavi Secretariat and Ministry of Health of Myanmar in the development of a roadmap for the establishment of a Programme Performance Monitoring Unit (PPMU), including its staffing,…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
2018 — 2018
Training the trainer for pandemic influenza preparedness...
MMGH supported the WHO Department of Infectious Hazard Management (IHM) in the preparation and facilitation of a workshop on country preparedness for vaccine deployment in the event of an influenza…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018
Seasonal influenza vaccination evaluation in Thailand, Morocco and Belarus...
A tablet-based Influenza Vaccine Post-Introduction Evaluation (IPIE) tool was developed by MMGH jointly with WHO, the U.S. Centers for Disease Control and Prevention (CDC) and the Swiss Tropical and Public…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2018 — 2018
Development of WHO’s pneumococcal vaccine position paper...
MMGH supported WHO in drafting the position paper on Pneumococcal conjugate vaccines (PCV) in infants and children under 5 years of age. The position paper summarises the evidence on the…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Related Publication(s)
Pneumococcal conjugate vaccines in infants and children under 5 years of age
Pneumococcal conjugate vaccines in infants and children under 5 years of age
Image Credit: Yasmina Guerda
2018 — 2018
Development of operational guidelines on equity in immunisation...
MMGH supported the WHO Regional Office for Europe in drafting operational guidelines for programme managers to measure inequities in immunisation, with a focus on understanding the root causes and implementing…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Akiko Harayama
2018 — 2018
Investment case for the Ending Cholera: A Global Roadmap to...
MMGH supported the Global Task Force on Cholera Control (GTFCC), on a Bill & Melinda Gates Foundation funded grant, in assessing and estimating the financial needs and benefits of the…
Client
Global Task Force on Cholera Control
Global Task Force on Cholera Control
Image Credit: MMGH/Carsten Mantel
2018 — 2018
Middle Income Countries strategy for the European region...
MMGH supported the WHO Regional Office for Europe in developing a strategic framework to address the challenges faced by the middle-income countries in the region. This framework informed the development…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018
Strategy for accelerated control of Japanese encephalitis in South East...
MMGH supported the WHO Regional Office for the Western Pacific in developing a guide for accelerating control of Japanese encephalitis (JE). The guide outlines regional targets, defines strategies and activities…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2017 — 2018
Influenza vaccine post-introduction evaluation (IPIE) in middle-income countries...
A tablet-based Influenza Vaccine Post-Introduction Evaluation (IPIE) tool was developed by MMGH jointly with WHO, the U.S. Centers for Disease Control and Prevention (CDC) and the Swiss Tropical and Public…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Thomas Cherian
2017 — Ongoing
Market Information for Access to Vaccine (MI4A) Initiative...
Since 2017, MMGH has provided ongoing support to the WHO Expanded Program on Immunisation's MI4A initiative aimed at enhancing countries’ access to safe, effective, quality, and affordable vaccines. MMGH consults…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Related Publication(s)
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance, Global market study: BCG vaccine, Global market update: BCG vaccine, Global market study: Diphtheria and Tetanus containing vaccines, Global market study: HPV vaccines, Global market study: Meningococcal meningitis vaccines, Global market study: Pneumococcal conjugate (PCV) and polysaccharide (PPV) vaccines, Global market study: Typhoid Vaccines
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance, Global market study: BCG vaccine, Global market update: BCG vaccine, Global market study: Diphtheria and Tetanus containing vaccines, Global market study: HPV vaccines, Global market study: Meningococcal meningitis vaccines, Global market study: Pneumococcal conjugate (PCV) and polysaccharide (PPV) vaccines, Global market study: Typhoid Vaccines
Image Credit: Lorenzo Pezzoli
2017 — 2017
Definition of the governance setup, funding framework and costing for...
MMGH supported the Global Task Force for Cholera Control in the definition of the new Cholera Control strategy. MMGH focused on the design of the governance and funding framework, as…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Related Publication(s)
Overview of ending cholera – A global roadmap to 2030
Overview of ending cholera – A global roadmap to 2030
2017 — 2017
Mid-Term review of the Regional Strategic Plan for Immunisation for...
MMGH supported the WHO Regional Office for Africa (AFRO) in performing the mid-term review of the Regional Strategic Plan for Immunisation 2014-2020. MMGH prepared an extensive desk review, facilitated a…
Client
World Health Organization (WHO)
World Health Organization (WHO)
Related Publication(s)
Mid-Term Review: Regional Strategic Plan for Immunisation 2014-2020
Mid-Term Review: Regional Strategic Plan for Immunisation 2014-2020
Image Credit: MMGH/Carsten Mantel
2017 — 2017
Review of Gavi-supported data strengthening activities...
MMGH supported the Monitoring & Evaluation Unit of the Gavi Secretariat in performing a review and synthesis of Gavi-funded data strengthening partner activities of WHO, UNICEF, US CDC, and WB…
Client
Gavi, The Vaccine Alliance
Gavi, The Vaccine Alliance
Image Credit: WHO
2017 — 2017
Review of Global Vaccine Action Plan 2011-2020...
MMGH supported the WHO Global Vaccine Action Plan (GVAP) Secretariat in developing a process and structure of the GVAP follow-up plan for the period 2021 - 2030. MMGH performed in-depth…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Lorenzo Pezzoli
2017 — 2017
Review of the Oral Cholera Vaccine Working Group of the...
MMGH supported the WHO in assessing the functioning of the Oral Cholera Vaccine (OCV) Working Group of the Global Task Force on Cholera Control (GTFCC). MMGH performed stakeholder interviews and…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2017 — 2017
Application for Gavi support for Human Papillomavirus and Rotavirus vaccine...
MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in developing two successful Gavi applications for the introduction of Human Papillomavirus and Rotavirus vaccines.
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: Akiko Harayama
2017 — 2017
Documentation of lessons learnt from the Oral Cholera Vaccine campaign...
MMGH supported the WHO Infectious Hazard Management (IHM) team in performing an evaluation of the management processes of the Oral Cholera Vaccine (OCV) campaign in Haiti. MMGH conducted interviews with…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2017 — 2017
Development of the WHO’s typhoid vaccines position paper...
MMGH supported the WHO Initiative for Vaccine Research (IVR) in facilitating a Strategic Advisory Group of Experts on Immunisation (SAGE) Working Group review of the scientific evidence and programmematic considerations…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
2017 — 2017
Immunisation Practices Advisory Committee (IPAC) ToR revision...
MMGH supported the WHO Immunisation Practices Advisory Committee (IPAC) Secretariat in revising the committee’s Terms of Reference (ToR). Based on information collected by MMGH during a series of in-depth stakeholder…
Client
World Health Organisation (WHO)
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2017 — 2017
Maternal Immunisation and Antenatal Care Situational Analysis (MIACSA)...
MMGH supported the WHO in conducting a Bill & Melinda Gates Foundation supported project that investigated and analysed the status of maternal immunisation delivery strategies in low and middle-income countries.…
Client
World Health Organization (WHO)
World Health Organization (WHO)
Related Publication(s)
Maternal Immunisation and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunisation delivery, Vaccine implementation factors affecting maternal tetanus immunisation in low- and middle-income countries: Results of the Maternal Immunisation and, Maternal immunisation country readiness: a checklist approach
Maternal Immunisation and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunisation delivery, Vaccine implementation factors affecting maternal tetanus immunisation in low- and middle-income countries: Results of the Maternal Immunisation and, Maternal immunisation country readiness: a checklist approach